Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0312414 (
Spotting
)
88
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Fertility Control Clinic, National University Hospital in Singapore carried out this study between Jan.1988-Dec.1988. In a comparison of present and past users of contraceptive implants (Norplant) or injectables (
DMPA
) and discontinuers of Norplant or
DMPA
, information concerning the women's knowledge and perception of, and attitude to, implants and injectable contraceptives, was studied. 200 married women ages 20-45 with at least 1 living child, who had used either method for at least 1 year, took part in this survey. The long duration of action (5 years) of implants was perceived positively by all groups as compared to the shorter 3-month duration of injectables, though this was seen as an advantage over the pill. 69% of implant users expressed a desire to continue using them, but only 30.7% of the injectable users wanted to continue using the method. 60% of the injectable users wanted to switch to implants, whereas no implant users desired a change. Women stopped using these 2 methods mainly because of the desire for a future pregnancy,
menstrual spotting
, and absence of menses. Norplant seems to be the ideal contraceptive in Singapore for women who do not want any more children or irreversible contraception.
...
PMID:Attitudes towards contraceptive implants and injectables among present and former users in Singapore. 210 23
Use of
Depo-Provera
for contraception during the postpartum period is reported. Contraceptive efficiency of 100% for more than 6 months was observed after injections of 150 mg on the 5th day postpartum and after 3 months. Estragenital and lactation side effects were negligeable.
Spotting
was observed in 21 patients, and bleeding in 7. Physiological amenorrhea continued to the 7th month in 24 patients. The authors believe that depoprovera is particularly indicated, and has fewer side effects, in the puerperium.
...
PMID:[Use of Depo Provera as a contraceptive in the puerperium]. 473 12